152 related articles for article (PubMed ID: 32110755)
21. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.
Heit JA; Armasu SM; Asmann YW; Cunningham JM; Matsumoto ME; Petterson TM; De Andrade M
J Thromb Haemost; 2012 Aug; 10(8):1521-31. PubMed ID: 22672568
[TBL] [Abstract][Full Text] [Related]
22. Replication of a genetic risk score for venous thromboembolism in whites but not in African Americans.
Folsom AR; Tang W; Weng LC; Roetker NS; Cushman M; Basu S; Pankow JS
J Thromb Haemost; 2016 Jan; 14(1):83-8. PubMed ID: 26565658
[TBL] [Abstract][Full Text] [Related]
23. Family history of myocardial infarction and cause-specific risk of myocardial infarction and venous thromboembolism: the Tromsø Study.
Lind C; Enga KF; Mathiesen EB; Njølstad I; Brækkan SK; Hansen JB
Circ Cardiovasc Genet; 2014 Oct; 7(5):684-91. PubMed ID: 25087051
[TBL] [Abstract][Full Text] [Related]
24. Myocardial Infarction as a Transient Risk Factor for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study.
Sejrup JK; Børvik T; Grimnes G; Isaksen T; Hindberg K; Hansen JB; Morelli VM; Brækkan SK
Thromb Haemost; 2019 Aug; 119(8):1358-1364. PubMed ID: 31203579
[TBL] [Abstract][Full Text] [Related]
25. Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.
Jarvis KB; LeBlanc M; Tulstrup M; Nielsen RL; Albertsen BK; Gupta R; Huttunen P; Jónsson ÓG; Rank CU; Ranta S; Ruud E; Saks K; Trakymiene SS; Tuckuviene R; Schmiegelow K
Thromb Res; 2019 Dec; 184():92-98. PubMed ID: 31715544
[TBL] [Abstract][Full Text] [Related]
26. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study.
Braekkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Størmer J; Hansen JB
J Thromb Haemost; 2008 Nov; 6(11):1851-7. PubMed ID: 18665924
[TBL] [Abstract][Full Text] [Related]
27. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study.
Hald EM; Lijfering WM; Mathiesen EB; Johnsen SH; Løchen ML; Njølstad I; Wilsgaard T; Rosendaal FR; Brækkan SK; Hansen JB
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):226-30. PubMed ID: 24177328
[TBL] [Abstract][Full Text] [Related]
28. The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer.
Ellingsen TS; Lappegård J; Skjelbakken T; Mathiesen EB; Njølstad I; Brækkan SK; Hansen JB
Res Pract Thromb Haemost; 2018 Apr; 2(2):327-333. PubMed ID: 30046735
[TBL] [Abstract][Full Text] [Related]
29. Heart healthy diet and risk of myocardial infarction and venous thromboembolism. The Tromsø Study.
Hansen-Krone IJ; Enga KF; Njølstad I; Hansen JB; Braekkan SK
Thromb Haemost; 2012 Sep; 108(3):554-60. PubMed ID: 22739999
[TBL] [Abstract][Full Text] [Related]
30. A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.
Tang W; Teichert M; Chasman DI; Heit JA; Morange PE; Li G; Pankratz N; Leebeek FW; Paré G; de Andrade M; Tzourio C; Psaty BM; Basu S; Ruiter R; Rose L; Armasu SM; Lumley T; Heckbert SR; Uitterlinden AG; Lathrop M; Rice KM; Cushman M; Hofman A; Lambert JC; Glazer NL; Pankow JS; Witteman JC; Amouyel P; Bis JC; Bovill EG; Kong X; Tracy RP; Boerwinkle E; Rotter JI; Trégouët DA; Loth DW; Stricker BHC; Ridker PM; Folsom AR; Smith NL
Genet Epidemiol; 2013 Jul; 37(5):512-521. PubMed ID: 23650146
[TBL] [Abstract][Full Text] [Related]
31. Comorbidity and risk of venous thromboembolism after hospitalization for first-time myocardial infarction: A population-based cohort study.
Würtz M; Grove EL; Corraini P; Adelborg K; Sundbøll J; Komjáthiné Szépligeti S; Horváth-Puhó E; Sørensen HT
J Thromb Haemost; 2020 Aug; 18(8):1974-1985. PubMed ID: 32319179
[TBL] [Abstract][Full Text] [Related]
32. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans.
Hooper WC; Lally C; Austin H; Benson J; Dilley A; Wenger NK; Whitsett C; Rawlins P; Evatt BL
Chest; 1999 Oct; 116(4):880-6. PubMed ID: 10531147
[TBL] [Abstract][Full Text] [Related]
33. Prothrombotic genotypes and risk of venous thromboembolism in cancer.
Gran OV; Brækkan SK; Hansen JB
Thromb Res; 2018 Apr; 164 Suppl 1():S12-S18. PubMed ID: 29703469
[TBL] [Abstract][Full Text] [Related]
34. Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study.
Småbrekke B; Rinde LB; Hindberg K; Hald EM; Vik A; Wilsgaard T; Løchen ML; Njølstad I; Mathiesen EB; Hansen JB; Brækkan S
PLoS One; 2016; 11(9):e0163242. PubMed ID: 27635655
[TBL] [Abstract][Full Text] [Related]
35. Genetic variations associated with recurrent venous thrombosis.
van Hylckama Vlieg A; Flinterman LE; Bare LA; Cannegieter SC; Reitsma PH; Arellano AR; Tong CH; Devlin JJ; Rosendaal FR
Circ Cardiovasc Genet; 2014 Dec; 7(6):806-13. PubMed ID: 25210051
[TBL] [Abstract][Full Text] [Related]
36. Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism-the Tromsø study.
Børvik T; Evensen LH; Morelli VM; Melbye H; Brækkan SK; Hansen JB
Res Pract Thromb Haemost; 2020 Feb; 4(2):255-262. PubMed ID: 32110756
[TBL] [Abstract][Full Text] [Related]
37. Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study.
Brækkan SK; Hald EM; Mathiesen EB; Njølstad I; Wilsgaard T; Rosendaal FR; Hansen JB
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):487-91. PubMed ID: 22075253
[TBL] [Abstract][Full Text] [Related]
38. Associations between polymorphisms in coagulation-related genes and venous thromboembolism: A meta-analysis with trial sequential analysis.
Jiang J; Liu K; Zou J; Ma H; Yang H; Zhang X; Jiao Y
Medicine (Baltimore); 2017 Mar; 96(13):e6537. PubMed ID: 28353616
[TBL] [Abstract][Full Text] [Related]
39. Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma.
Horváth-Puhó E; Suttorp MM; Frederiksen H; Hoekstra T; Dekkers OM; Pedersen L; Cannegieter SC; Dekker FW; Sørensen HT
Clin Epidemiol; 2018; 10():1371-1380. PubMed ID: 30310329
[TBL] [Abstract][Full Text] [Related]
40. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
Carr BR; Ory H
Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
